Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 5
2005 2
2006 6
2007 3
2008 2
2009 3
2010 1
2011 3
2012 5
2013 9
2014 9
2015 7
2016 12
2017 7
2018 9
2019 7
2020 13
2021 12
2022 9
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Cafaro A, Foca F, Nanni O, Chiumente M, Coppola M, Baldo P, Orzetti S, Enrico F, Ladisa V, Lerose R, Nardulli P, Maiolino P, Gradellini F, Gasbarro AR, Carrucciu G, Provasi R, Cappelletto PC, Pasqualini A, Vecchia S, Veraldi M, De Francesco AE, Crinò L, Delmonte A, Masini C. Cafaro A, et al. Among authors: nanni o. Front Oncol. 2024 Mar 27;14:1351995. doi: 10.3389/fonc.2024.1351995. eCollection 2024. Front Oncol. 2024. PMID: 38601759 Free PMC article.
Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.
Rossi R, Cravero P, Pallotti MC, Valenti V, Massa I, Foca F, Nanni O, Pieri M, Romeo A, Tontini L, Donati CM, Morganti AG, Maltoni M. Rossi R, et al. Among authors: nanni o. J Pain Symptom Manage. 2024 Mar 10:S0885-3924(24)00655-9. doi: 10.1016/j.jpainsymman.2024.03.001. Online ahead of print. J Pain Symptom Manage. 2024. PMID: 38467347 No abstract available.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Schettini F, Palleschi M, Mannozzi F, Brasó-Maristany F, Cecconetto L, Galván P, Mariotti M, Ferrari A, Scarpi E, Miserocchi A, Nanni O, Sanfeliu E, Prat A, Rocca A, De Giorgi U. Schettini F, et al. Among authors: nanni o. Oncologist. 2024 Jan 4:oyad337. doi: 10.1093/oncolo/oyad337. Online ahead of print. Oncologist. 2024. PMID: 38175669 Free article.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
Bersanelli M, Verzoni E, Cortellini A, Giusti R, Calvetti L, Ermacora P, Di Napoli M, Catino A, Guadalupi V, Guaitoli G, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Perrone F, Maruzzo M, Rossi E, Casadei C, Montesarchio V, Grossi F, Rizzo M, Travagliato Liboria MG, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Camerini A, Sorarù M, Zucali PA, Ricciardi S, Russo A, Negrini G, Banzi MC, Lacidogna G, Fornarini G, Laera L, Mucciarini C, Santoni M, Mosillo C, Bonetti A, Longo L, Sartori D, Baldini E, Guida M, Iannopollo M, Bordonaro R, Morelli MF, Tagliaferri P, Spada M, Ceribelli A, Silva RR, Nolè F, Beretta G, Giovanis P, Santini D, Luzi Fedeli S, Nanni O, Maiello E, Labianca R, Pinto C, Clemente A, Tognetto M, De Giorgi U, Pignata S, Di Maio M, Buti S, Giannarelli D; FICOG group (Federation of Italian Cooperative Oncology Groups). Bersanelli M, et al. Among authors: nanni o. EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37434748 Free PMC article.
Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
Montroni I, Ugolini G, Saur NM, Rostoft S, Spinelli A, Van Leeuwen BL, De Liguori Carino N, Ghignone F, Jaklitsch MT, Kenig J, Garutti A, Zingaretti C, Foca F, Vertogen B, Nanni O, Wexner SD, Audisio RA; SIOG Surgical Task Force/ESSO GOSAFE Study Group. Montroni I, et al. Among authors: nanni o. J Clin Oncol. 2023 Dec 1;41(34):5247-5262. doi: 10.1200/JCO.22.02195. Epub 2023 Jun 30. J Clin Oncol. 2023. PMID: 37390383
TransFAIR study: a European multicentre experimental comparison of EHR2EDC technology to the usual manual method for eCRF data collection.
Ammour N, Griffon N, Djadi-Prat J, Chatellier G, Lewi M, Todorovic M, Gómez de la Cámara A, García Morales MT, Testoni S, Nanni O, Schindler C, Sundgren M, Garvey A, Victor T, Cariou M, Daniel C. Ammour N, et al. Among authors: nanni o. BMJ Health Care Inform. 2023 Jun;30(1):e100602. doi: 10.1136/bmjhci-2022-100602. BMJ Health Care Inform. 2023. PMID: 37316249 Free PMC article.
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol.
Valenti V, Rossi R, Scarpi E, Dall'Agata M, Bassi I, Cravero P, La Manna G, Magnoni G, Marchello M, Mosconi G, Nanni O, Nava S, Pallotti MC, Rapposelli IG, Ricci M, Scrivo A, Spazzoli A, Valenti D, Zambianchi L, Caraceni A, Maltoni M. Valenti V, et al. Among authors: nanni o. BMJ Open. 2023 May 30;13(5):e065971. doi: 10.1136/bmjopen-2022-065971. BMJ Open. 2023. PMID: 37253494 Free PMC article.
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk, et al. Lancet. 2023 Apr 15;401(10384):1277-1292. doi: 10.1016/S0140-6736(23)00285-4. Lancet. 2023. PMID: 37061269 Free PMC article.
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Bottoni G, Fiz F, Puntoni M, Matteucci F, Monti M, DeCensi A, Nanni O, Brain E, Alberini JL, Dib B, Sacchetti G, Trimboli P, Treglia G, Harbeck N, Sola S, Gennari A, Piccardo A. Bottoni G, et al. Among authors: nanni o. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2477-2485. doi: 10.1007/s00259-023-06173-9. Epub 2023 Mar 7. Eur J Nucl Med Mol Imaging. 2023. PMID: 36879065
122 results